Novacyt announced today that it is collaborating with AstraZeneca (NYSE:AZN), GlaxoSmithKline (NYSE:GSK) and the University of Cambridge to increase testing in the United Kingdom. Pharmaceutical companies AstraZeneca and GSK, along with the University of Cambridge, are slated to set up a new testing laboratory at Cambridge’s Anne McLaren lab. The facility will be used for high throughput […]
Novacyt
Novacyt reports skyrocketing demand for its coronavirus test
Novacyt announced that its Primerdesign molecular diagnostics division sold and received orders for more than $10.1 million (£8.7 million) of its COVID-19 tests. The company’s United Kingdom–based molecular diagnostics arm offered the update on its CE-Marked, research-use-only coronavirus tests, having previously announced that it sold and received orders for over $5 million of its tests […]